Abstract. Artemisinin combination therapies are available in private outlets, but patient adherence might be compromised by poor advice from dispensers. In this cluster randomized trial in drug shops in Tanzania, 42 of 82 selected shops were randomized to receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL). Eligible patients purchasing AL at shops in both arms were followed up at home and questioned about each dose taken. Dispensers were interviewed regarding knowledge of AL dispensing practices and receipt of the malaria-related text messages. We interviewed 904 patients and 110 dispensers from 77 shops. Although there was some improvement in dispenser knowledge, there was no difference ...
Patients' low adherence to artemisinin-based combination therapy has been reported in areas of Kenya...
Adherence to artemisinin-based combination therapies (ACTs) for malaria is important for effective ...
Abstract Background Prompt access to artemesinin-combination therapy (ACT) is not adequate unless th...
Artemisinin combination therapies are available in private outlets, but patient adherence might be c...
Artemisinin combination therapies are available in private outlets, but patient adherence might be c...
BACKGROUND: Low rates of adherence to artemisinin-based combination therapy (ACT) regimens increase ...
<div><p>Background</p><p>Low rates of adherence to artemisinin-based combination therapy (ACT) regim...
Background: Low rates of adherence to artemisinin-based combination therapy (ACT) regimens increase ...
The failure of patients to adhere to recommended treatment guidelines is a major driver of widesprea...
In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administ...
In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administ...
In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administ...
Abstract Background Increasing affordability of artemisinin combination therapy (ACT) in the African...
BackgroundArtemisinin combination therapy (ACT) is first-line treatment for malaria in most endemic ...
BACKGROUND: Short Message Service (SMS) reminders have been suggested as a potential intervention fo...
Patients' low adherence to artemisinin-based combination therapy has been reported in areas of Kenya...
Adherence to artemisinin-based combination therapies (ACTs) for malaria is important for effective ...
Abstract Background Prompt access to artemesinin-combination therapy (ACT) is not adequate unless th...
Artemisinin combination therapies are available in private outlets, but patient adherence might be c...
Artemisinin combination therapies are available in private outlets, but patient adherence might be c...
BACKGROUND: Low rates of adherence to artemisinin-based combination therapy (ACT) regimens increase ...
<div><p>Background</p><p>Low rates of adherence to artemisinin-based combination therapy (ACT) regim...
Background: Low rates of adherence to artemisinin-based combination therapy (ACT) regimens increase ...
The failure of patients to adhere to recommended treatment guidelines is a major driver of widesprea...
In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administ...
In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administ...
In Nigeria, access to malaria diagnostics may be expanded if drug retailers were allowed to administ...
Abstract Background Increasing affordability of artemisinin combination therapy (ACT) in the African...
BackgroundArtemisinin combination therapy (ACT) is first-line treatment for malaria in most endemic ...
BACKGROUND: Short Message Service (SMS) reminders have been suggested as a potential intervention fo...
Patients' low adherence to artemisinin-based combination therapy has been reported in areas of Kenya...
Adherence to artemisinin-based combination therapies (ACTs) for malaria is important for effective ...
Abstract Background Prompt access to artemesinin-combination therapy (ACT) is not adequate unless th...